Search - tctmd.com

Displaying 1 - 20 of 47

Sort: Relevancy | Date

News Daily News

Patient Age Adds Key Context to D-Dimer in DVT Diagnosis: ADJUST-DVT

Caitlin E. Cox

January 08, 2026

News Daily News

Asundexian Reduces Recurrent Stroke Without Bleeding Risk: OCEANIC-STROKE

Michael O'Riordan

November 24, 2025

News Conference News ESC 2025

HI-PRO: Oral Apixaban for 1 Year Protective, Safe in Provoked VTE Patients

Caitlin E. Cox

September 01, 2025

News Conference News ACC 2025

Low-Dose Apixaban Prevents Recurrent VTE in Cancer Beyond 6 Months: API-CAT

Caitlin E. Cox

March 29, 2025

News Daily News

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

L.A. McKeown

August 19, 2024

News Opinion CV Team Dispatch

May 2024 Dispatch for the CV Team

L.A. McKeown

May 01, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2024

Shelley Wood

February 01, 2024

News Daily News

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

Shelley Wood

January 17, 2024

News Daily News

AHA Selects 2023’s Leading Cardiovascular Research

Todd Neale

December 22, 2023

News Conference News ISET 2023

BEST-CLI: Experts at ISET Look to Bridge Research Results and Practice

Caitlin E. Cox

January 25, 2023

News Daily News

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

Michael O'Riordan

October 20, 2022

News Conference News TCT 2022

FLASH: More Data to Support Mechanical Thrombectomy in PE

L.A. McKeown

September 18, 2022

News Opinion Editor's Corner ESC 2022

What’s Going to Be Hot at ESC 2022?

Shelley Wood

August 22, 2022

News Daily News

Worse Complications After PVI in Women Highlight Research Gaps

L.A. McKeown

August 16, 2022

News Daily News

SCAI-Led Position Statement on CLTI Spotlights Multispeciality Involvement

L.A. McKeown

April 27, 2022

News Daily News

No Increased Bleeding With Alteplase in Stroke Patients on DOACs: Registry Data

Yael L. Maxwell

February 15, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2022

Shelley Wood

January 31, 2022

News Daily News

AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD

Caitlin E. Cox

December 28, 2021

News Daily News

Predictors of AF May Help Guide Care After Stroke of Unknown Cause

Caitlin E. Cox

October 26, 2021

News Daily News

Rivaroxaban Again Linked to More Bleeding vs Other DOACs

Caitlin E. Cox

October 11, 2021

Advertisement

Patient Age Adds Key Context to D-Dimer in DVT Diagnosis: ADJUST-DVT

Asundexian Reduces Recurrent Stroke Without Bleeding Risk: OCEANIC-STROKE

HI-PRO: Oral Apixaban for 1 Year Protective, Safe in Provoked VTE Patients

Low-Dose Apixaban Prevents Recurrent VTE in Cancer Beyond 6 Months: API-CAT

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

May 2024 Dispatch for the CV Team

TCTMD’s Top 10 Most Popular Stories for January 2024

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

AHA Selects 2023’s Leading Cardiovascular Research

BEST-CLI: Experts at ISET Look to Bridge Research Results and Practice

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

FLASH: More Data to Support Mechanical Thrombectomy in PE

What’s Going to Be Hot at ESC 2022?

Worse Complications After PVI in Women Highlight Research Gaps

SCAI-Led Position Statement on CLTI Spotlights Multispeciality Involvement

No Increased Bleeding With Alteplase in Stroke Patients on DOACs: Registry Data

TCTMD’s Top 10 Most Popular Stories for January 2022

AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD

Predictors of AF May Help Guide Care After Stroke of Unknown Cause

Rivaroxaban Again Linked to More Bleeding vs Other DOACs

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content